Abstract: The present invention relates to the inhibition of the circulating extracellular form of the interferon inducible protein 16 (extracellular IFI16) for the treatment of diseases, particularly autoimmune and/or inflammatory disorders or infective disorders.
Type:
Application
Filed:
January 28, 2011
Publication date:
March 7, 2013
Applicant:
Universita degli Studi del Piemonte Orientale "A Avogedro" (University of Piemonte Orientale)